These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 29113302)

  • 1. Clinical evaluation of palliative chemoradiotherapy for metastatic esophageal cancer.
    Ueda H; Takeda M; Ueda S; Kawakami H; Okuno T; Takegawa N; Hayashi H; Tsurutani J; Tamura T; Ishikawa K; Nishimura Y; Nakagawa K
    Oncotarget; 2017 Oct; 8(46):80286-80294. PubMed ID: 29113302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palliative concurrent chemoradiotherapy in locally advanced and metastatic esophageal cancer patients with dysphagia.
    Akl FM; Elsayed-Abd-Alkhalek S; Salah T
    Ann Palliat Med; 2013 Jul; 2(3):118-23. PubMed ID: 25842093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of concurrent chemoradiotherapy as a palliative treatment in stage IVB esophageal cancer patients with dysphagia.
    Ikeda E; Kojima T; Kaneko K; Minashi K; Onozawa M; Nihei K; Fuse N; Yano T; Yoshino T; Tahara M; Doi T; Ohtsu A
    Jpn J Clin Oncol; 2011 Aug; 41(8):964-72. PubMed ID: 21742654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent chemoradiotherapy with S-1 and cisplatin in advanced esophageal cancer.
    Cho SH; Shim HJ; Lee SR; Ahn JS; Yang DH; Kim YK; Nam TK; Lee JJ; Kim HJ; Chung IJ
    Dis Esophagus; 2008; 21(8):697-703. PubMed ID: 18522639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
    Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
    Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advanced esophageal cancer: toxicity and outcome.
    Hurmuzlu M; Monge OR; Smaaland R; Viste A
    Dis Esophagus; 2010 Apr; 23(3):244-52. PubMed ID: 19664075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z; Zhang Z; Jin J; Ajani JA; Swisher SG; Stevens CW; Ho L; Smythe R; Vaporciyan AA; Putnam JB; Walsh GL; Roth JA; Yao JC; Allen PK; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1484-93. PubMed ID: 15590179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin in advanced oesophageal cancer.
    Shim HJ; Kim DE; Hwang JE; Bae WK; Nam TK; Na KJ; Cho SH; Chung IJ
    Cancer Chemother Pharmacol; 2012 Nov; 70(5):683-90. PubMed ID: 22932694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.
    Kato K; Nakajima TE; Ito Y; Katada C; Ishiyama H; Tokunaga SY; Tanaka M; Hironaka S; Hashimoto T; Ura T; Kodaira T; Yoshimura K
    Jpn J Clin Oncol; 2013 Jun; 43(6):608-15. PubMed ID: 23585687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer.
    Miyazaki T; Sohda M; Tanaka N; Suzuki S; Ieta K; Sakai M; Sano A; Yokobori T; Inose T; Nakajima M; Fukuchi M; Ojima H; Kato H; Kuwano H
    Cancer Chemother Pharmacol; 2015 Mar; 75(3):449-55. PubMed ID: 25544126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy.
    Adelstein DJ; Rice TW; Rybicki LA; Larto MA; Ciezki J; Saxton J; DeCamp M; Vargo JJ; Dumot JA; Zuccaro G
    J Clin Oncol; 2000 May; 18(10):2032-9. PubMed ID: 10811667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capecitabine and cisplatin chemotherapy (XP) alone or sequentially combined chemoradiotherapy containing XP regimen in patients with three different settings of stage IV esophageal cancer.
    Lee SS; Kim SB; Park SI; Kim YH; Ryu JS; Song HY; Shin JH; Jung HY; Lee GH; Choi KD; Cho KJ; Kim JH
    Jpn J Clin Oncol; 2007 Nov; 37(11):829-35. PubMed ID: 17951334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.
    Zhang Z; Liao Z; Jin J; Ajani J; Chang JY; Jeter M; Guerrero T; Stevens CW; Swisher S; Ho L; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):656-64. PubMed ID: 15708243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction Chemotherapy Followed by Concurrent Chemoradiotherapy in Locoregional Esophageal Cancer.
    Lee GW; Kang JH; Kim HG; Hwang IG; Shim KS; Kim SH; Lee WS; Jung WT; Lee OJ; Cho JH; Jang JS; Chae KY; Lee JS
    Cancer Res Treat; 2001 Dec; 33(6):489-94. PubMed ID: 26680828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concurrent chemoradiotherapy or endoscopic stenting for advanced squamous cell carcinoma of esophagus: a case-control study.
    Wong SK; Chiu PW; Leung SF; Cheung KY; Chan AC; Au-Yeung AC; Griffith JF; Chung SS; Ng EK
    Ann Surg Oncol; 2008 Feb; 15(2):576-82. PubMed ID: 18057993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
    Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
    Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent chemoradiotherapy for locally advanced and metastatic esophageal cancer: longterm results of a phase II study of UFT/CDDP with radiotherapy.
    Iwase H; Shimada M; Nakamura M; Nakarai K; Iyo T; Kaida S; Indo T; Kato E; Horiuchi Y; Kusugami K
    Int J Clin Oncol; 2003 Oct; 8(5):305-11. PubMed ID: 14586756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study of paclitaxel, carboplatin, and radiation with or without surgery for esophageal cancer.
    Wang H; Ryu J; Gandara D; Bold RJ; Urayama S; Tanaka M; Goldberg Z; Follette D; Narayan S; Lau D
    J Thorac Oncol; 2007 Feb; 2(2):153-7. PubMed ID: 17410032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with cisplatin concurrent chemoradiotherapy for nonmetastatic Stage IV head-and-neck squamous cell carcinomas.
    Prestwich RJ; Öksüz DÇ; Dyker K; Coyle C; Şen M
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e237-43. PubMed ID: 21620580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.